Douglas E. Vaughan

Douglas E. Vaughan

Cardiology

675 N St Clair St Ste 19-100
Galter Pavilion
Chicago, IL 60611

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 74 publications

A tribute to Eugene Braunwald (1929-2026).

A tribute to Eugene Braunwald (1929-2026).

Journal: The Journal of clinical investigation

Published: June 15, 2026

Functional, molecular, and digital measurements of biological age.

Functional, molecular, and digital measurements of biological age.

Journal: The Journal of clinical investigation

Published: June 15, 2026

Metabolic Vulnerability Index and Risk of Total Mortality: Findings From the Multi-Ethnic Study of Atherosclerosis.

Metabolic Vulnerability Index and Risk of Total Mortality: Findings From the Multi-Ethnic Study of Atherosclerosis.

Journal: Circulation. Population health and outcomes

Published: February 20, 2026

Metabolic Vulnerability Index and Risk of Total Mortality: Findings From the Multi-Ethnic Study of Atherosclerosis.

Metabolic Vulnerability Index and Risk of Total Mortality: Findings From the Multi-Ethnic Study of Atherosclerosis.

Journal: Circulation. Population health and outcomes

Published: February 20, 2026

Erythroid-produced intact FGF23 is a paracrine inhibitor of erythropoiesis.

Erythroid-produced intact FGF23 is a paracrine inhibitor of erythropoiesis.

Journal: Blood

Published: July 01, 2025

Plasminogen activator inhibitor 1 promotes aortic aging-like pathophysiology in humans and mice.

Plasminogen activator inhibitor 1 promotes aortic aging-like pathophysiology in humans and mice.

Journal: The Journal of clinical investigation

Published: June 12, 2025

PAI-1 is a common driver of aging and diverse diseases.

PAI-1 is a common driver of aging and diverse diseases.

Journal: Biomedical journal

Published: May 14, 2025

Role of plasminogen activator inhibitor-1 (PAI-1) in age-related cardiovascular pathophysiology.

Role of plasminogen activator inhibitor-1 (PAI-1) in age-related cardiovascular pathophysiology.

Journal: The journal of cardiovascular aging

Published: January 01, 2025

Mouse model hints at pharmacogenomic strategies for stroke treatment in patients possessing a risk variant.

Mouse model hints at pharmacogenomic strategies for stroke treatment in patients possessing a risk variant.

Journal: The Journal of clinical investigation

Published: September 15, 2023

Associations between GrimAge acceleration and pulmonary function in the Coronary Artery Risk Development in Young Adults (CARDIA) study.

Associations between GrimAge acceleration and pulmonary function in the Coronary Artery Risk Development in Young Adults (CARDIA) study.

Journal: Epigenomics

Published: September 11, 2023

Inequalities in urban greenness and epigenetic aging: Different associations by race and neighborhood socioeconomic status.

Inequalities in urban greenness and epigenetic aging: Different associations by race and neighborhood socioeconomic status.

Journal: Science advances

Published: June 28, 2023

Pharmacological inhibition of plasminogen activator inhibitor-1 prevents memory deficits and reduces neuropathology in APP/PS1 mice.

Pharmacological inhibition of plasminogen activator inhibitor-1 prevents memory deficits and reduces neuropathology in APP/PS1 mice.

Journal: Psychopharmacology

Published: January 16, 2023

Showing 1-12 of 74

Last Updated: 09/26/2026